Best Chronic Myeloid Leukemia Podcasts (2025)

1
Phosphoseryl-tRNA kinase inhibition in acute myeloid leukemia (AML), APOE gene variants and post-hematopoietic stem cell transplant outcomes in AML, and the role of chronic inflammation in sickle cell ... 19:06

5d ago19:06

19:06

In this week's episode we’ll learn more about how phosphoseryl-tRNA kinase inhibition promotes cell death in acute myeloid leukemia, or AML; APOE gene variants and their association with post-hematopoietic stem cell transplant outcomes in AML; and pathways by which chronic inflammation and oxidative stress may lead to cardiomyopathy in patients wit…

1
Non–Cystic Fibrosis (CF) Bronchiectasis in Adults 23:16

13h ago23:16

23:16

Non-cystic fibrosis (CF) bronchiectasis, which affects approximately a half million people in the US, is a chronic lung condition that involves permanent bronchial dilation and inflammation; it is characterized by a productive cough and recurrent exacerbations. Author Alan F. Barker, MD, of Oregon Health and Science University joins JAMA Deputy Edi…

1
Shingles Vaccination and Dementia, Varenicline for Vaping Cessation, Mental Health Trends in Publicly Insured Children, and more 10:13

3d ago10:13

10:13

Editor’s Summary by Preeti Malani, MD, MS, and Chris Muth, MD, Deputy Editors of JAMA, the Journal of the American Medical Association, for articles published from April 19-25, 2025.

1
How Pharmacists Can Enhance Comprehensive Patient-Centered Care for Patients With HR+/HER2- MBC and Comorbidities 16:41

4d ago16:41

16:41

In this podcast episode, Allison Butts, PharmD, BCOP, reviews how pharmacists can help in providing comprehensive patient-centric care for patients with HR+/HER2- MBC and preexisting comorbid conditions, including: Common comorbidities and complexities in managing patients with HR+/HER2- MBC Treatment landscape for patients with HR+/HER2- MBC Real-…

1
The Latest Evidence on Targeting B7-H3 in Small Cell Lung Cancer 18:34

5d ago18:34

18:34

In this episode, hear Lauren Byers, MD and Christine Hann, MD share their insights on the latest data regarding new therapies targeting B7-H3 in small cell lung cancer including: Rationale for targeting B7-H3 Overview of the structure of antibody-drug conjugates (ADCs) Results from the phase I/II IDeate-PanTumor01 trial of ifinatamab deruxtecan (I-…

1
Vitamin D Guidelines for Healthy Children and Adults 18:01

5d ago18:01

18:01

A JAMA Clinical Guidelines Synopsis summarizes the Endocrine Society’s most recent recommendations on vitamin D supplementation for disease prevention. Author Sherri-Ann M. Burnett-Bowie, MD, MPH, discusses this and more with JAMA Associate Editor David L. Simel, MD, MHS. Related Content: Vitamin D for Prevention of Disease…

1
The Lay of the Land: Overview of Biology of HER2 in Genitourinary, Gastrointestinal, and Gynecologic Malignancies 14:09

7d ago14:09

14:09

In this episode, Zev A. Wainberg, MD; Funda Meric-Bernstam, MD; Alexandra Leary, MD, PhD; and Catherine Fahey, MD, PhD, explore testing for HER2 alterations and the incidence of HER2-positive disease in the treatment of genitourinary, gastrointestinal, and gynecologic malignancies. HER2 Testing in Advanced Cancers: Recommendations for when and how …

1
Sex-Based Differences in Alcohol Consumption, ICU Patient Outcomes, Trends After Drug Decriminalization in British Columbia, and more 8:59

10d ago8:59

8:59

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from April 12-18, 2025.

1
How I Treat Myeloproliferative Neoplasms 38:36

12d ago38:36

38:36

In this How I Treat series episode Blood Associate Editor, Dr. Jason Gotlib speaks with Drs. Aaron Gerds, Andreas Reiter, and Claire Harrison. The conversation focuses on the work and contributions of these authors to How I Treat Myeloproliferative Neoplasms, and exciting advances in the treatment and management of MPNs. See the full How I Treat se…

1
The decline of transplant for relapsed myeloma; DDAVP response in bleeding disorders; dual DOT1L/EZH2 targeting in DLBCL 18:49

12d ago18:49

18:49

In this week's episode we'll learn about the role of autologous transplant for relapsed myeloma. In an updated analysis of the GMMG ReLApsE trial, salvage autologous transplant offered no survival benefit compared to control chemotherapy. These findings may have clinical implications in an era of alternative, and highly effective, treatment options…

1
Discussing Surgery With Patients 12:12

12d ago12:12

12:12

What are 3 fundamental communication skills needed when discussing surgery with patients? Author Lauren J. Taylor, MD, of the Central Virginia VA Health Care System discusses this and more with JAMA Senior Editor Anne Cappola, MD, ScM. Related Content: Communicating With Patients About Surgery

1
Cancer, Siblings, and Jennie Milton's MacGyver Mindset 48:56

13d ago48:56

48:56

On Navigating Cancer TOGETHER, join Talaya Dendy as she welcomes Jennie 'AdrenaJen' Milton (author, snow kiter, and resilience coach). Jennie shares her inspiring family journey with her brother's three-time cancer survival and her struggles overcoming depression and brain aneurysms. Discover her 'MacGyver mindset' for tackling life's challenges an…

1
Trends in Group A Strep Infections, Outcome Measurements for Community-Acquired Sepsis, USPSTF Recommendations for Breastfeeding Counseling, and more 8:18

17d ago8:18

8:18

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from April 5-11, 2025.

1
Interleukin-1 signaling pathways in myelodysplastic syndromes, the immune checkpoint regulator VISTA as a target in graft-vs-host disease, and epcoritamab plus chemotherapy in transplant-ineligible relapsed ... 20:59

19d ago20:59

20:59

In this week's episode we’ll learn about the role of interleukin-1 signaling in the bone marrow microenvironment in the development of myelodysplastic syndromes, the immune checkpoint regulator VISTA as a potential target for preventing graft-vs-host disease, and epcoritamab plus gemcitabine and oxaliplatin in transplant-ineligible relapsed/refract…

1
Prothrombin Complex Concentrate for Coagulopathic Bleeding After Cardiac Surgery, IV Iron for Patients w/ Heart Failure and Iron Deficiency, Cardiac Arrest and Long-Distance Races, and more 10:13

25d ago10:13

10:13

Editor's Summary by Linda Brubaker, MD, MS, and Chris Muth, MD, Deputy Editors of JAMA, the Journal of the American Medical Association, for articles published from March 29-April 4, 2025.

1
Aging platelets shift to proinflammatory function; Odronextamab bispecific antibody therapy after CAR T in DLBCL; prizlon-cel, a novel bispecific CAR T, in B-NHL 15:26

26d ago15:26

15:26

In this week's episode we'll learn about tracking the functional profile of aging platelets. Researchers demonstrate that over time, platelet function shifts away from hemostasis and toward a more immunomodulatory role. These finding could have important implications for transfusion medicine and certain platelet-related disease states. After that, …

1
The Year I Waited: Understanding Why We Delay Our Health 17:50

27d ago17:50

17:50

Why do we wait? Why do we sometimes ignore those nagging health concerns? Join host Talaya Dendy on Navigating Cancer TOGETHER as she shares her journey of delaying medical attention for a year after a doctor dismissed her initial worries. Discover the relatable reasons behind her hesitation, from the pressures of work and family to the underlying …

1
Blood Bonus Episode: What is a Blood group? 14:59

29d ago14:59

14:59

In this bonus episode of the Blood podcast, we'll hear from Dr. Nicole Thornton, senior author of the article “Deletions in the MAL gene result in loss of Mal protein, defining the rare inherited AnWj-negative blood group phenotype”, speaks with Blood Associate Editor Dr. Erica Wood about the discovery of the genetic basis for the inherited AnWj-ne…

1
Treatment of Small Cell Lung Cancer 11:47

29d ago11:47

11:47

Small cell lung cancer (SCLC) is a smoking-related malignancy that presents at an advanced stage in 70% of patients. Author Anne C. Chiang, MD, PhD, of the Yale University School of Medicine joins JAMA Senior Editor Karen Lasser, MD, MPH, to discuss the epidemiology, treatment, and prognosis of SCLC. Related Content: Small Cell Lung Cancer…

1
Diagnosing Prostate Cancer w/ Microultrasonography-Guided Biopsy, Long-Term Risk of Stroke After TIA or Minor Stroke, Beneficiary Savings w/ Medicare $2 Drug List Model, and more 8:06

1M ago8:06

8:06

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from March 22-28, 2025.

1
Itacitinib in haploidentical hematopoietic cell transplantation, diagnosis and management of purpura fulminans, and lack of evidence for sickle cell crisis-associated mortality in individuals with sickle ... 19:16

1M ago19:16

19:16

In this week's episode, we’ll learn more about using itacitinib for the prevention of graft vs host disease in haploidentical transplants, diagnosis and management of purpura fulminans, and results of a systematic review seeking evidence for sickle cell crisis-associated mortality in individuals with sickle cell trait. Featured Articles: Itacitinib…

1
Oncologist On-Call: Thoughts on the Current Treatment Landscape for First-line Management of HER2-Positive mBC 14:42

1M ago14:42

14:42

In this episode, listen to Stephanie L. Graff, MD, FACP, FASCO; and Laura M. Spring, MD, share their clinical insights and takeaways regarding the current treatment landscape for first-line treatment of patients with HER2-positive metastatic breast cancer including: Data from multicenter, single-arm, phase IIIb/IV DESTINY-Breast12 evaluating trastu…

1
Diagnosis, Treatment, and Prognosis of Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Adults 22:33

1M ago22:33

22:33

Polycystic kidney disease is the most common genetic kidney disease worldwide and is characterized by progressive development of kidney cysts. Author Nerra Dahl, MD, PhD, Mayo Clinic, discusses the pathophysiology, clinical presentation, diagnosis, prognosis, and treatment of ADPKD in adults, with JAMA Associate Editor David Simel, MD, MHS. Related…

1
Sevoflurane for Sedation in ARDS, A Reinforcement Learning Model for Second-Line Vasopressin for Septic Shock, Chronic Myeloid Leukemia Review, and more 9:37

1M ago9:37

9:37

Editor’s Summary by JAMA Deputy Editors Linda Brubaker, MD, and Preeti Malani, MD, MSJ, for articles published from March 15-21, 2025.

1
Time-limited triplet therapy in relapsed/refractory CLL; patient-reported outcomes in chronic GVHD-related sclerosis; myeloid bias mechanisms in hematopoiesis 19:07

1M ago19:07

19:07

In today's episode, we'll discuss time-limited triplet therapy in relapsed or refractory CLL. Zanubrutinib, venetoclax and obinutuzumab induced deep remissions, and was well tolerated, even in very high-risk patients, and those with prior exposure to targeted therapies. After that: researchers chronicle the development of a patient-reported outcome…

1
C.H.L.M.S. Medi-Helpz: Strengthening Healthcare Advocacy 49:23

1M ago49:23

49:23

Ever feel lost in the maze of healthcare? As part of Podcasthon, Talaya Dendy sits down with Sandra Washington in this powerful and special episode. Sandra is the driving force behind C.H.L.M.S. Medi-Helpz, and she shares her incredible journey as a patient, revealing the raw, personal inspiration that sparked her mission to bridge the healthcare g…

1
Chronic Myeloid Leukemia: A Review 17:21

1M ago17:21

17:21

Chronic myeloid leukemia is a myeloproliferative neoplasm that affects approximately 5 million people worldwide. Tyrosine kinase inhibitors, such as imatinib, have substantially improved survival in patients with chronic myeloid leukemia. In this podcast, author Elias J. Jabbour, MD, of the University of Texas MD Anderson Cancer Center, discusses d…

1
Immunotherapy for Head, Neck, and Nasopharyngeal Cancers, High-Dose Vitamin D for Multiple Sclerosis, the USPSTF Food Insecurity Screening Recommendation, and more 12:45

2M ago12:45

12:45

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from March 8-14, 2025.

1
Azacitidine plus venetoclax in high-risk myelodysplastic syndromes, post-CAR T-cell hematotoxicity in B-cell acute lymphoblastic leukemia (B-ALL), and inotuzumab ozogamicin resistance in B-ALL 21:28

2M ago21:28

21:28

In this week's episode we’ll learn more about azacitidine-venetoclax combination therapy for first-line treatment of high-risk myelodysplastic syndromes; a new risk-scoring system for post-CAR T-cell hematotoxicity in B-cell acute lymphoblastic leukemia, also known as B-ALL; and a novel mechanism for inotuzumab ozogamicin resistance in B-ALL. Featu…

1
Navigating Cancer Shock: Tips for Immediate Self-Care 27:14

2M ago27:14

27:14

In this episode of Navigating Cancer TOGETHER, host Talaya Dendy continues her personal story, sharing her initial reactions to being diagnosed with stage three Hodgkin's lymphoma. Talaya recounts the emotional journey following a devastating phone call on a Friday evening, the impact it had on her weekend, and the steps she took to calm herself an…

1
USPSTF Recommendation: Screening for Food Insecurity 13:39

2M ago13:39

13:39

Interview with Tumaini Rucker Coker, MD, MBA, USPSTF member and coauthor of Screening for Food Insecurity: US Preventive Services Task Force Recommendation Statement. Hosted by JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS. Related Content: Preventive Services for Food Insecurity Food Insecurity, Health, and Health Care in the US Navig…

1
Localized and Metastatic Prostate Cancer 18:07

2M ago18:07

18:07

Prostate cancer is the most common nonskin cancer in men in the US and the second most common cancer in men worldwide. Author R. Bruce Montgomery, MD, of the University of Washington joins JAMA Senior Editor Karen Lasser, MD, MPH, to discuss the current evidence regarding the epidemiology, diagnosis, and management of localized and metastatic prost…

1
Protein S Abnormalities and Thrombosis, Coronary Artery Calcium Scoring, Cancer Screening Post-Pandemic, and more 11:35

2M ago11:35

11:35

Editor’s Summary by Linda Brubaker, MD, Deputy Editor of JAMA, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from March 1-7, 2025.

1
Mutations in AMBRA1 aggravate β-thalassemia; targeting MYD88 mutations in lymphomas; air pollution and incident VTE risk 17:48

2M ago17:48

17:48

In this week's podcast, a potential new therapeutic target in beta-thalassemia. The E3 ubiquitin ligase AMBRA1 promotes autophagic clearance of free alpha-globin. Researchers describe mutations in the AMBRA1 gene that impair this clearance, exacerbating ineffective erythropoiesis and disease severity. After that: targeting MYD88 mutations. Lasaloci…

Podcasts Worth a Listen

Chronic Myeloid Leukemia Podcasts

Podcasts Worth a Listen